The Indianapolis-based company expanded its spend to ensure it can meet growing demand for its weight-loss drugs.
An article from
Dive Brief
The Indianapolis-based company expanded its spend to ensure it can meet growing demand for its weight-loss drugs.
Published May 8, 2026
A sign with the company logo sits outside of Eli Lilly & Co.’s headquarters in Indianapolis, Indiana. The pharmaceutical giant said it plans to invest an additional $4.5 billion at two of its three manufacturing sites in Lebanon, Indiana.
Eli Lilly is committing to its roots, allocating $4.5 billion for new manufacturing investments across Indiana as drugmakers…
More production capacity for the obesity pill is crucial as Eli Lilly races to bring it to market and tries to maintain its…
Medical company Eli Lilly said Tuesday around $5 billon will be go toward construction of its new facility in Virginia just west…
That added production capacity for Eli Lilly's obesity pill, orforglipron, is crucial as the company races to file for its…
The plant will help make Lilly's experimental drug called retatrutide, which has shown the highest weight loss seen to date in a…
Indianapolis-based Eli Lilly intends to build a biomanufacturing facility that would cost $6.5 billion to build and employ 4,000+…
